Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
US Application 62/295,421
Filed on 2016-02-15
Filed on 2016-02-15
PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF
US Application 62/666,471
Filed on 2018-05-03
Filed on 2018-05-03
COMPOSITIONS AND METHODS FOR MODULATING ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION
US Application 62/661,234
Filed on 2018-04-23
Filed on 2018-04-23
CANCER TREATMENT METHODS
US Application 62/685,026
Filed on 2018-06-14
Filed on 2018-06-14
Compound and METHODS OF TREATING HBV
US Application 62/685,145
Filed on 2018-06-14
Filed on 2018-06-14
COMBINATION OF NEAR INFRARED PHOTOIMMUNOTHERAPY TARGETING CANCER CELLS AND HOST-IMMUNE ACTIVATION
US Application 62/655,612
Filed on 2018-04-10
Filed on 2018-04-10
METHODS OF PRODUCING T CELL POPULATIONS USING A HYDROXCITRATE SALT
US Application 62/661,941
Filed on 2018-04-24
Filed on 2018-04-24
Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data
US Application 62/650,162
Filed on 2018-03-29
Filed on 2018-03-29
ACTIVATORS OF TYPE II NKT CELLS AND METHODS OF USE THEREOF
US Application 62/648,167
Filed on 2018-03-26
Filed on 2018-03-26
Targeted Combination Therapy
US Application 62/484,693
Filed on 2017-04-12
Filed on 2017-04-12